Syndax Pharmaceuticals
Biotechnology
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on oncology, with two commercially approved medicines: Revuforj (revumenib) and Niktimvo (axatilimab).
- Revuforj (revumenib)
- Niktimvo (axatilimab)
Open roles at Syndax Pharmaceuticals
3 matching roles
Unspecified
New York City, New York, United States +1 more
Director
$235k to $260k USD
- Management Occupations
- Biometrics
Posted 1 week ago
Source: Greenhouse
Unspecified
New York City, New York, United States +1 more
Contract · Manager
Salary unavailable
- Management Occupations
- Biometrics
Posted 3 weeks ago
Source: Greenhouse
Unspecified
New York City, New York, United States +1 more
Contract · Lead
Salary unavailable
- Biometrics
Posted 3 weeks ago
Source: Greenhouse
Showing 3 of 3 roles